For the benefits of human genetics and genomics to be truly universal, the data upon which these advancements are built must reflect the rich tapestry of human variation. Historically, medical research has struggled with a lack of diversity, often excluding marginalized populations and leaving significant gaps in our understanding of disease risk and treatment efficacy. Today, a concerted effort by the scientific community, policymakers, and local advocates is working to bridge this divide, placing engagement with individuals and communities at the center of the discovery process.
Central to this movement is the "In Our DNA SC" project, an ambitious initiative based at the Medical University of South Carolina (MUSC). By aiming to enroll 100,000 participants through no-cost genetic testing, the project seeks to build a database that mirrors the diverse population of South Carolina. Among those leading the charge is Lee H. Moultrie II, a retired U.S. Air Force veteran, healthcare advocate, and prostate cancer survivor whose story illuminates the profound, real-world impact of genetic inquiry.
The Pillars of Modern Genomic Research
The American Society of Human Genetics (ASHG) has long emphasized that human genetics is more than just data—it is a deeply personal field that affects families and communities. By sharing narratives like Mr. Moultrie’s, the organization seeks to honor participants and highlight how scientific inquiry serves as a catalyst for advocacy and public awareness.
Policymakers play a pivotal role in this landscape. ASHG maintains an active dialogue with Congress and other governing bodies to communicate how investments in genetics translate into improved healthcare outcomes and, ultimately, hope for patients. However, the success of these policy efforts depends on a fundamental shift in how research is conducted: moving from a transactional model to one rooted in trust and partnership.
A Chronology of Advocacy and Participation
Lee H. Moultrie II’s journey into the world of genetic research did not begin in a lab, but through a lifetime of community service. At 67, as an African American man who has survived a nine-year battle with prostate cancer, Moultrie has spent his life advocating for civil rights and better healthcare access.
His path to "In Our DNA SC" was defined by a desire to leave a legacy of health for future generations. "As a civil rights activist and healthcare advocate, I became even more excited to see that I could participate in a project of this nature for free," Moultrie explains. He viewed his participation as a way to engage in something larger than himself, potentially advancing personalized medicine for his family, his neighbors, and society at large.
The timeline of his involvement reflects a growing trend: patients are no longer passive subjects but active partners. Following his decision to join the study, Moultrie took the initiative to inform his local community, even writing an Op-Ed in a local newspaper. His call to action—urging community members to fight historical medical injustices by volunteering for the future—sparked a chain reaction of engagement, from academics and students to local business owners, including his own barber.
Supporting Data: The Case for Representative Research
The scientific community recognizes that genomic medicine is only as effective as the data it utilizes. Currently, a significant portion of genetic research data is derived from populations of European ancestry. This bias creates a "genomic divide," where risk prediction scores for cancer, heart disease, and other conditions are less accurate for non-European individuals.
The "In Our DNA SC" initiative addresses this by targeting a 100,000-person cohort that accurately represents the demographic reality of South Carolina. The benefits are threefold:
- Empowerment: Participants gain a deeper understanding of their genetic risk profiles for hereditary conditions.
- Equity: It promotes equitable access to genetic counseling and specialized healthcare, removing the cost barrier.
- Personalized Medicine: The data allows clinicians to tailor prevention strategies, such as lifestyle adjustments or specialized screenings, to an individual’s unique genetic makeup.
Official Perspectives: Trust as a Foundation
The challenge of building trust between researchers and the public is significant, particularly among African American communities who have historically been mistreated by the medical establishment.
"Trust should be a key element to all our relationships," Moultrie asserts. He argues that the research community must prioritize "relationship over transaction." This sentiment is echoed by public health experts who cite works like Dr. Uché Blackstock’s Legacy: A Black Physician Reckons With Racism In Medicine, which posits that systemic change requires concrete actions rather than mere rhetoric.
From the researcher’s perspective, the goal is to create a transparent environment where participants feel their data is protected and respected. As Moultrie notes, participants are "trusting researchers to safeguard our DNA, adhering strictly to the terms of our agreement regarding its use for scientific purposes and ensuring it is not commodified or sold."
Implications: The Future of Personalized Healthcare
The implications of increased participation in genetic research are far-reaching. For individuals like Moultrie, the results of genetic analysis provide a roadmap for the future. "This is the next level of personalizing my health care," he says, "enabling me to strive towards reaching the age of 100 or beyond."
1. Societal and Generational Impact
The knowledge gained through these studies is not merely for the individual; it is an inheritance for the next generation. By understanding their genetic predispositions, families can take proactive measures to mitigate risk. As Moultrie observes, he has children and grandchildren who benefit from his increased awareness.
2. The Role of Community Elders
The involvement of community elders is essential. They act as bridges between scientific institutions and younger generations. By "passing the baton," they ensure that the lessons learned from both historical medical failures and modern successes are carried forward.
3. Strengthening the Scientific Ecosystem
For researchers, the influx of diverse data allows for more robust scientific inquiry. It provides the statistical power needed to identify rare variants and understand how gene-environment interactions influence health outcomes across different ethnicities. To sustain this, however, the research community must continue to advocate for the necessary funding to push the boundaries of knowledge.
Conclusion: A Call to Action
The story of Lee H. Moultrie II is a testament to the power of individual agency in the face of complex scientific challenges. It highlights a critical truth: the future of medicine is not just about the technology in our labs, but the relationships in our communities.
As we look toward a future where genomics is integrated into routine primary care, the collaborative model pioneered by programs like "In Our DNA SC" will be the gold standard. It requires scientists to step out of the lab and into the community, and it requires community members to see themselves as vital partners in the discovery process.
When asked what he would want a geneticist to know, Moultrie’s answer is simple yet profound: "How can we better work together to get the message out so that more people can come to the table?" The answer lies in transparency, mutual respect, and the shared goal of a healthier, more equitable future for everyone.
By prioritizing diversity and fostering trust, we can ensure that the "hope" generated by human genetics research is not just a promise for the few, but a reality for the many. The path forward is built on the willingness of people like Lee Moultrie to share their stories, their DNA, and their dedication to the greater good. As the scientific community continues to refine its approach, it is clear that the most important element of any research study is the human connection that fuels it.
About the Author
